在斑点叉尾血清中强力霉素对嗜水气单胞菌药动-药效模型研究

为合理应用强力霉素治疗斑点叉尾(Ictalurus punctatus)细菌性败血症,采用体内药动学和体外药效学相结合的方法,研究了斑点叉尾血清中强力霉素抗嗜水气单胞菌(Aeromonas hydropila)的活性,数据使用3p97和kinetica4.4软件分析。结果表明:强力霉素在普通肉汤培养基和血清中对嗜水气单胞菌的最小抑菌浓度(MIC)均为2.0μg/mL。斑点叉尾按20 mg/kg体重的剂量口灌强力霉素后,药物吸收迅速、达峰快、消除缓慢,血浆药物达峰时间(Tmax)为2.57h,峰浓度(Cmax)为1.72μg/mL,消除半衰期[T(1/2)β]为38.63h。在半效应室内,半效浓度参数(EC50)为16.95h,即血清药物浓度为1.41μg/mL时可产生50%最大效应。PK-PD同步模型参数Cmax/MIC血清为0.86,AUC0→24h/MIC血清为20.57h。通过抑制效应的Sigmoid Emax模型方程可得到临床起到抑菌效果的最佳给药剂量范围为10.68—41.42 mg/kg体重。临床上发生斑点叉尾细菌性败血症时的最佳给药方案建议为:对出现临床病状的斑点叉尾以41.42 mg/kg体重的剂量进行拌饲投喂进行治疗,1次/d。临床上预防斑点叉尾细菌性败血症时以10.68 mg/kg体重的剂量进行拌饲投喂,1次/d。     

嗜麦芽寡养单胞菌胞外蛋白酶功能研究进展

嗜麦芽寡养单胞菌(Stenotrophomonas maltophilia)是广泛分布于自然界的革兰氏阴性杆菌。作为一种新型、与高死亡率相关的条件致病菌,嗜麦芽寡养单胞菌能够导致人类或其他生物感染多种疾病。近年来,越来越多的研究结果显示来自于细菌的胞外蛋白酶是导致宿主发病的关键蛋白质。因此,探究嗜麦芽寡养单胞菌胞外蛋白酶的组成成分和功能将不仅有助于阐明其致病机制,更为今后以其为靶点进行临床治疗奠定基础。本文试图对嗜麦芽寡养单胞菌胞外蛋白酶的性质、功能及其应用进行归纳总结。     

三种室内饲养鱼类肠道微生物群落PCR-DGGE指纹分析

以室内饲养的斑点叉尾(Ictalurus punctatus)、银鲫和异育银鲫(中科三号)(Carassius auratus gibelio)幼鱼为对象,通过PCR-DGGE指纹技术对其肠道微生物群落进行了探索研究。在三种鱼的肠道中检测到不同的PCR-DGGE指纹谱带,其中斑点叉尾的平均谱带数(7.5)相对于银鲫和异育银鲫的谱带数(分别为15和14)要少。基于PCR-DGGE指纹谱带及各谱带相对丰度的UPGMA聚类和MDS排序结果显示银鲫和异育银鲫肠道微生物相似性高,而与斑点叉尾的差异比较大;rank-abundance散点图及回归分析也显示斑点叉尾与银鲫、异育银鲫肠道微生物群落存在显著差异(P0.05),而银鲫和异育银鲫之间无显著差异(P=0.383)。在斑点叉尾肠道中检测到的菌群主要是变形杆菌,包括-变形杆菌和-变形杆菌;而银鲫和异育银鲫肠道中菌群主要包括梭杆菌属中的类群,还包括变形杆菌门中的气单胞菌属,以及一些未知的类群。以上结果均表明在所研究的三种鱼的幼鱼阶段,其肠道微生物组成在不同种类鱼中存在差异,且该差异受基因型的影响可能更大。       

斑点叉尾鮰一株致病菌的分离鉴定及系统发育分析

从发生急性流行性传染病的斑点叉尾肝、肾分离到一高致病性的菌株(CCF00024),经人工感染实验证实其为该病的病原菌。对该菌的形态、生理生化及16S rDNA序列分析结果表明,其为非发酵型,严格需氧,革兰氏阴性杆菌,极生多鞭毛,对除麦芽糖和甘露糖以外的多种糖类不能利用产酸,氧化酶阴性,DNA酶、蛋白酶、脲酶、赖氨酸脱羧酶阳性,MR阴性。在以该菌16S rDNA序列(GenBank登录号AY970826)和GenBank及RDP数据库内同源性较高的细菌16S rDNA序列构建的系统发育树中,分离菌CCF00024与嗜麦芽寡养单胞菌(Stenotrophomonasmaltophilia)聚在一簇,特别是与S.maltophiliaM5-1的同源性最高,其序列相似性达99.6%,结合形态和生理生化特点将其鉴定为嗜麦芽寡养单胞菌(Stenotrophomonas maltophilia)。     

台州地区708株嗜麦芽寡养单胞菌耐药性变迁研究

目的了解708株嗜麦芽寡养单胞菌构成比及耐药性的变迁,探讨引起耐药性变迁的危险因素、指导临床合理使用抗生素。方法对台州医院2003年至2007年嗜麦芽寡养单胞菌数据进行回顾性研究,统计分析该菌在标本来源构成比、不同科室阳性标本构成比及抗生素耐药率等方面的变迁。结果近5年来,嗜麦芽寡养单胞菌的分离率以痰标本中最高（83.6%）;科室分布2003年至2005年间以脑外科及ICU最高,此后血液肿瘤内科跃居第一;该菌对抗生素的耐药性呈普遍上升趋势。结论注意空气消毒是减少嗜麦芽寡养单胞菌通过呼吸道传播的有效措施;ICU、脑外科及血液肿瘤内科仍需加强护理等措施。避免抗生素的不正当使用及外部设备的长期使用,有利于避免耐药菌的产生,有效控制院感。     

鲁氏耶尔森氏菌口服微球疫苗特性分析及免疫效果研究

为制备并评价鲁氏耶尔森氏菌口服微球疫苗的免疫效果,实验采用天然高分子聚合物海藻酸钠为疫苗载体,鲁氏耶尔森氏菌灭活疫苗为抗原,制备鲁氏耶尔森氏菌口服疫苗。以拌料口服方式进行免疫,通过血清非特异免疫指标、抗体效价、免疫保护率等综合评价疫苗的免疫效果。结果表明,鲁氏耶尔森氏菌口服微球疫苗成球性好,粒径均匀,粒径(8.761.73) m,跨距0.47,包封效率94.51%,具备良好的抗酸性、肠溶性及高安全性的特点。将疫苗免疫斑点叉尾,能显著提高斑点叉尾血清中溶菌酶活力、总超氧化物歧化酶活力(T-SOD)以及补体替代途径活性(ACH50);血清凝集效价于第5周达到峰值为1:8,至免疫后第8周仍能检测到特异性抗体;口服鲁氏耶尔森氏菌微球疫苗的斑点叉尾获得的抗鲁氏耶尔森氏菌相对免疫保护率为65.52%。综上所述,实验制备的鲁氏耶尔森氏菌口服微球疫苗能够对鲁氏耶尔森氏菌病起到较好的预防作用。       

斑点叉尾(鱼回)一株致病菌的分离鉴定及系统发育分析

从发生急性流行性传染病的斑点叉尾NFDA5肝、肾分离到一高致病性的菌株（CCF00024）,经人工感染实验证实其为该病的病原菌。对该菌的形态、生理生化及16S rDNA序列分析结果表明,其为非发酵型,严格需氧,革兰氏阴性杆菌,极生多鞭毛,对除麦芽糖和甘露糖以外的多种糖类不能利用产酸,氧化酶阴性,DNA酶、蛋白酶、脲酶、赖氨酸脱羧酶阳性,MR阴性。在以该菌16S rDNA序列（GenBank登录号AY970826）和GenBank及RDP数据库内同源性较高的细菌16S rDNA序列构建的系统发育树中,分离菌CCF00024与嗜麦芽寡养单胞菌（Stenotrophomonas maltophilia）聚在一簇,特别是与S. maltophilia M51的同源性最高,其序列相似性达99.6%,结合形态和生理生化特点将其鉴定为嗜麦芽寡养单胞菌（Stenotrophomonas maltophilia）。     

嗜麦芽寡养单胞菌胞外产物对斑点叉尾损伤的病理学研究

采用硫酸铵盐析从嗜麦芽假单胞菌培养物中提取其胞外产物,通过腹腔注射方式,进行了嗜麦芽假单胞菌(P.maltophilia)胞外产物对斑点叉尾(Ictalurus punctatus)损伤的系统病理学研究。结果表明,嗜麦芽假单胞菌胞外产物具有较强的毒力,对斑点叉尾(42.5±4.4)g的半致死剂量(LD50)为3.21mg蛋白/kg体重。病鱼出现神经症状,腹部和下颌充血、出血,腹部膨大,腹腔内充满大量淡黄色或带血的腹水,胃肠道黏膜充血、出血,肠套叠,肝、脾、肾肿大等临床病变。组织学病变主要表现为全身多组织、器官水肿,出血、变性、坏死以及炎症反应,特别是脑、骨骼肌、肝、脾、肾和胃肠道的损伤较为严重。超微结构观察发现病鱼肝、脾、肾和骨骼肌等器官的细胞的超微结构均有较为严重的破坏,线粒体肿胀,嵴断裂或溶解消失,呈空囊状,内质网扩张,细胞核变形,染色质溶解或固缩;研究中还发现嗜麦芽假单胞菌胞外产物可致淋巴细胞凋亡,脾和肾间质内淋巴细胞均表现为细胞核染色质浓缩边移,或核固缩成一个或数个团块凝聚在核膜周边,形成凋亡小体。       

嗜麦芽寡养单胞菌临床分布特征与耐药分析

目的了解湖州市中心医院嗜麦芽寡养单胞菌临床分布特征与耐药性。方法采用常规方法分离,用VITE-COMPACT2全自动微生物分析仪进行菌种鉴定,用K—B法进行药敏试验。结果分离到嗜麦芽寡养单胞菌810株,复方新诺明耐药菌株48株（分离率5．9％）。标本来源主要来自ICU室,其次呼吸科,大部分来自痰液标本（约占89．2％）,年龄段以中老年人比率最高。嗜麦芽寡养单胞菌对亚胺培南、美罗培南、头孢吡肟、哌拉西彬他坐巴坦、庆大霉素、妥布霉素、阿米卡星高度耐药;头孢他啶、替卡西林／克拉维酸、环丙沙星耐药率为33．7％～58．2％;头孢哌酮／舒巴坦、左氧氟沙星、米诺环素、复方新诺明耐药率低于30．0％。复方新诺明耐药菌株对头孢哌酮／舒巴坦、左氧氟沙星和米诺环素耐药率分别为60．4％、91．7％和2．0％,对其余抗菌药物耐药率达100．0％。复方新诺明耐药菌株与复方新诺明敏感菌株相比,耐药情况更严重,其中对三、四代头孢菌素、喹诺酮类耐药率显著高于复方新诺明敏感菌株（P〈0．01）;对碳青霉烯类、青霉素类、氨基糖苷类抗菌药物耐药率与复方新诺明敏感菌株相比,差异无统计学意义（P〉0．05）。结论嗜麦芽寡养单胞菌呈高度耐药,对头孢哌酮／舒巴坦、左氧氟沙星、米诺环素、复方新诺明尚敏感,但对复方新诺明耐药的嗜麦芽寡养单胞菌耐药现象更严重。应重视嗜麦芽寡养单胞菌引起的院内感染,尽量减少不必要的侵人性操作,加强抗菌药物的合理规范使用。     

斑点叉尾鮰套肠症的病原学初步研究

本研究从2例垂死的患败血症并肠套叠的斑点叉尾鮰血液、肝脏及脑组织中分离到2种类型的致病性细菌菌株,经对细菌进行形态观察、生理生化测试和16S rDNA序列分析,分别鉴定为嗜水气单胞菌和荧光假单胞菌;攻毒实验证实它们确为斑点叉尾鮰病鱼的病原。根据药敏实验的结果,及时对病区斑点叉尾鮰进行治疗,连续用药3-5天,发病的叉尾鮰即停止死亡。根据研究结果,文章对斑点叉尾鮰肠套叠发生的原因进行了的分析,提出了不同的观点。     

无花果多糖对鲫鱼非特异性免疫功能的影响

实验研究了无花果多糖对鲫鱼非特异性免疫功能的影响。将鲫鱼分成A0、A1、A2、A3和A4五个组,其中A0组投喂基础饵料,设为对照组,而A1、A2、A3和A4分别投喂添加0.1%、0.2%、0.4%、0.8%无花果多糖的基础饵料,并在试验的第0、第7、第14、第21、第28、第35天检测鲫鱼血清补体C3含量、总蛋白含量、溶菌酶活力、SOD活性和血液白细胞吞噬活性。结果表明,A2组的补体C3含量、总蛋白含量、溶菌酶活力、SOD活性和血液白细胞吞噬活性显著高于A0组(P3组补体C3含量、SOD活性和血液白细胞吞噬活性极显著的高于A0组(P1组、A4组(P3组补体C3含量、总蛋白含量、溶菌酶活力、SOD活性和血液中白细胞吞噬活性与A2组相比差异不显著。A0组、A1组和A4组之间的补体C3含量、总蛋白含量、溶菌酶活力、SOD活性和血液白细胞吞噬活性无显著差异(P>0.05)。       

Bactericidal response of channel catfish (Ictalurus punctatus) by the classical and alternative complement pathways against bacterial pathogens

The alternative and classical complement pathways of channel catfish (Ictalurus punctatus), most importantly the classical complement pathway which requires antibody, demonstrated bactericidal activity against two Gram-negative bacterial fish pathogens, Flexibacter columnaris and Vibrio anguillarum. This shows the importance of antibody-mediated bactericidal immunity in fish by the classical complement pathway in providing protection following immunization or natural infections.     

Immunological effectiveness of a dried group-A meningococcal polysaccharide vaccine

The immunological effectiveness of dried group A meningococcal polysaccharide vaccine, developed at the Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow, for children aged 5-14 years was studied. The intensiveness of the immune response of children to 0.5 ml of the vaccine introduced in a single injection was evaluated by a rise in the level of agglutinating antibodies to group A meningococcal polysaccharide in the sera of the vaccinees 3-4 weeks after immunization with the following optimum doses: 25 micrograms for children aged 5-8 years, 50 micrograms for children aged 9-13 years and 75 micrograms for children aged 14 years and over. The vaccine was shown to be highly immunogenic. Antibodies to group A meningococcal polysaccharide were identified as IgM. These antibodies in a titer of 1:40 and higher could be detected in 90% of the vaccinated children in the younger age group, 7 months after immunization.     

Immunologic memory response induced by a meningococcal serogroup C conjugate vaccine using the P64k recombinant protein as carrier

In this study, we used an adoptive lymphocyte transfer experiment to evaluate the ability of the P64k recombinant protein to recruit T-helper activity and induce immunologic memory response to the polysaccharide moiety in a meningococcal serogroup C conjugate vaccine. Adoptive transfer of splenocytes from mice immunized with the glycoconjugate conferred antipolysaccharide immunologic memory to naive recipient mice. The observed anamnestic immune response was characterized by more rapid kinetics, isotype switching from IgM to IgG and higher antipolysaccharide antibody titers compared with those reached in groups transferred with splenocytes from plain polysaccharide or phosphate-immunized mice. The memory response generated was also long lasting. Sera from mice transferred with cells from conjugate-immunized mice were the only protective in the infant rat passive protection assay, and also showed higher bactericidal titers. We demonstrated that priming the mice immune system with the glycoconjugate using the P64k protein as carrier induced a memory response to the polysaccharide, promoting a switch of the T-cell-independent response to a T-cell dependent one.     

Membrane damage to Escherichia coli and bactericidal kinetics by the alternative complement pathway of channel catfish

1. Increased permeability of cytoplasmic membranes in Escherichia coli was a consequence of alternative complement pathway (ACP) activity of serum of channel catfish, Ictalurus punctatus. Evidence was provided by beta-galactosidase activity extracellularly when E. coli was incubated with catfish serum. 2. Lesions were detected on outer membranes of E. coli following exposure to catfish serum. 3. Catfish ACP induced a temporal sequence of pre-killing and killing phases. 4. Loss of cell viability, killing rate and cytoplasmic enzyme release increased with increasing serum concentrations. 5. By incubating E. coli with sera treated to remove complement, both release of cytoplasmic enzyme and bactericidal activity were eliminated. 6. Lethal activity associated with channel catfish ACP against Gram-negative bacteria was functionally comparable to that seen in mammalian and reptilian systems.     

Agglutinating and Bactericidal Properties of Fractions of Rabbit Anti-Vibrio cholerae Serum

The major portion of the agglutinating and bactericidal activity of the sera of rabbits immunized with live Vibrio cholerae or with cholera vaccine was found in the gammaM fractions during the early stages of immunization. After 5 weeks or more, gammaG fractions accounted for more than half of the agglutinating activity. When late antibody was measured as the amount of protein precipitated by somatic antigens, nearly 3 times as much gammaG as gammaM was required for agglutination, and about 30 times as much gammaG as gammaM was required to kill 50% of a standard inoculum in the presence of complement. The ratio of vibriocidal to agglutinin titer of gammaG fractions at different stages of immunization was more variable than that of gammaM fractions. More complement was required for a vibriocidal effect by gammaG than by gammaM. Increasing the amount of complement decreased the amount of both gammaG and gammaM required to kill, but smaller amounts of gammaM required disproportionately larger amounts of complement. Less time was required by gammaM than by gammaG to kill 50% of the inoculum. Removal of the group-reactive antibody from anti-Ogawa serum and serum fractions by absorption with Inaba reduced the vibriocidal titer by more than one-half.     

Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa

Background

The meningococcal serogroup A (MenA) polysaccharide conjugate vaccine used in Sub-Saharan Africa does not prevent disease caused by MenW or MenX strains, which also cause epidemics in the region. We investigated the vaccine-potential of native outer membrane vesicles with over-expressed factor H-binding protein (NOMV-fHbp), which targeted antigens in African meningococcal strains, and was combined with a MenA polysaccharide conjugate vaccine.

Methodology/Principal Findings

The NOMV-fHbp vaccine was prepared from a mutant African MenW strain with PorA P1.5,2, attenuated endotoxin (ΔLpxL1), deleted capsular genes, and over-expressed fHbp in variant group 1. The NOMV-fHbp was adsorbed with Al(OH)₃ and used to reconstitute a lyophilized MenA conjugate vaccine, which normally is reconstituted with liquid MenC, Y and W conjugates in a meningococcal quadrivalent conjugate vaccine (MCV4-CRM, Novartis). Mice immunized with the NOMV-fHbp vaccine alone developed serum bactericidal (human complement) activity against 13 of 15 African MenA strains tested; 10 of 10 African MenX strains, 7 of 7 African MenW strains, and 6 of 6 genetically diverse MenB strains with fHbp variant group 1 (including 1 strain from The Gambia). The combination NOMV-fHbp/MenA conjugate vaccine elicited high serum bactericidal titers against the two MenA strains tested that were resistant to bactericidal antibodies elicited by the NOMV-fHbp alone; the combination elicited higher titers against the MenA and MenW strains than those elicited by a control MCV4-CRM vaccine (P<0.05); and high titers against MenX and MenB strains. For most strains, the titers elicited by a control NOMV-fHbp knock out vaccine were <1∶10 except when the strain PorA matched the vaccine (titers >1∶000).

Conclusion/Significance

The NOMV-fHbp/MenA conjugate vaccine provided similar or higher coverage against MenA and MenW strains than a quadrivalent meningococcal conjugate vaccine, and extended protection against MenX strains responsible for epidemics in Africa, and MenB strains with fHbp in variant group 1.     

The characteristics of the antibody response of animals immunized with components of the surface structures of Francisella tularensis

Antibody formation in animals immunized with one of the components of F. tularensis surface structures was studied. The time course of antibody formation in 20 hamadryas baboons was studied in the passive hemagglutination (PHA) test, microagglutination (MA) test, and indirect enzyme immunoassay, used for the determination of IgG, IgA and IgM antibodies. The character of antibody response in the animals immunized with components of F. tularensis surface structures (S-complex) and with live tularemia vaccine was compared. The study revealed that immunization with the S-complex induced the formation of antibodies detected by all three methods. Antibody formation to the S-complex was found to be dose-dependent. With the increase of the injected dose of the S-complex, antibody titers determined in the PHA test decreased and those determined in the MA test increased, which was seemingly due to the induction of antibodies differing in their isotypes. After immunization with the S-complex the levels of IgG antibodies were lower and the levels of IgM antibodies by day 28 after immunization higher than after the injection of live tularemia vaccine.